Financing channel feed

Cana­di­an biotech VC Am­pli­tude rais­es $192M sec­ond fund

12 months ago
Startups

Ex­clu­sive: SR One rais­es $200M+ for third fund, still with GSK sup­port

Last year

Start­up launch­es with ‘RNA sen­sor’ tech­nol­o­gy from Stan­ford and MIT to bet­ter con­trol mR­NA ther­a­pies

Last year

Grey Wolf reels in $50M to ex­pand in­to au­toim­mune dis­eases

Last year
Startups

Ver­sant has a new obe­si­ty biotech. As­traZeneca has the op­tion to buy it

Last year
Startups
Pharma

With a fresh $100M, Monte Rosa CEO de­tails plans to move sev­er­al mol­e­c­u­lar glues in­to the clin­ic

Last year

Al­tru­Bio se­cures $225M for an up­dat­ed ver­sion of its ul­cer­a­tive col­i­tis drug

Last year
Startups

ADC biotech Pheon rais­es $120M to test three as­sets in the clin­ic

Last year
Startups

UK biotech rais­es £35M to de­vel­op sol­id tu­mor drugs based on ma­chine learn­ing

Last year
R&D

Prog­en­tos emerges with $65M for mul­ti­ple scle­ro­sis tri­als with IP from Fre­quen­cy

Last year
Startups

Rap­port, a clin­i­cal-stage neu­ro­science biotech, files for IPO

Last year
Startups

Aus­tralian ra­dio­phar­ma Telix launch­es bid for Nas­daq list­ing

Last year

GSK, UK gov­ern­ment bud­get £130M to fight glob­al an­timi­cro­bial re­sis­tance

Last year
Pharma

Ex­clu­sive: Gas­tro­pare­sis biotech Cin­Dome se­cures $40M for path to piv­otal tri­al

Last year
R&D

Up­dat­ed: Black­stone com­mits $300M to a for­mer Mer­ck an­ti­body for asth­ma, COPD

Last year
Deals

Up­dat­ed: Sands Cap­i­tal rais­es $555M for third life sci­ences fund

Last year
Startups

Car­olyn Bertozzi-found­ed Ly­cia Ther­a­peu­tics rais­es $106M to en­ter the clin­ic

Last year
Startups

New­Vale un­veils $167M fund to back phar­ma ser­vice providers and 'old ideas that are work­ing'

Last year
Outsourcing
Manufacturing

'At­tack JAK': Ajax se­cures $95M to test new JAK2 in­hibitor af­ter in­dus­try's string of myelofi­bro­sis deals

Last year
Startups

Up­dat­ed: France draws €2B+ re­search, man­u­fac­tur­ing in­vest­ment from Sanofi, Pfiz­er, As­traZeneca, GSK

Last year
Manufacturing

Verona inks fi­nanc­ing deal worth up to $650M ahead of COPD de­ci­sion

Last year
Marketing

In­fec­tious dis­ease biotech Blue­jay rais­es $182M for he­pati­tis tri­als

Last year
Startups

At­tovia reels in $105M from crossover in­vestors to run mul­ti­ple tri­als of I&I bi­o­log­ics

Last year
Startups

Aard­vark nabs $85M to tar­get hunger, not ap­petite, as it eyes 2026 NDA fil­ing

Last year
Startups
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times